Are pharma companies pulling their money out of the U.K. because of Trump? And how is biotech M&A pacing this year?

The Senate health committee has invited health secretary Robert F. Kennedy Jr. to testify before the panel amid allegations ...

Federal workers send Congress a letter pleading for help, but their trouble attracting signatures reflects fear of ...

The WHO said Thursday that 31 of 38 confirmed Ebola cases have resulted in deaths in southern Congo, where authorities are ...

Califf warns AI in health care 'overhyped' On a makeshift stage in a Midtown Manhattan office earlier this week,former Food and Drug Administration ...

The chair of a key vaccine committee that advises the CDC will strike a confrontational tone at meeting of the panel, ...

Novo Nordisk's diabetes blockbuster Ozempic beat Eli Lilly’s older drug Trulicity in a real-world study of certain U.S. patients ...

Also, fun note: My dad co-authored a First Opinion article for STAT on the potential impact of AI chatbots on psychosis. But ...

In July, President Trump signed an executive order that, among other things, aimed to expand involuntary commitments as part ...

Sangamo Therapeutics hasn’t convinced a pharma company to buy its experimental gene therapy for Fabry disease after two years ...

Scientists seeking NIH funding for projects involving overseas partners will encounter a new grant system starting early next year.

Just like a mirror can distort as much as it reflects, LLMs’ distortion of reality can have real mental health risks that are ...